HIV/AIDS Clinical Trials in Phoenix

Showing 281-300 of 518 trials

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

NCT02026752

The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. The plasma samples will be tested in a method comparison study to support the approval of the Aptima HIV-1 assay on Gen-Probe's Panther testing system. The objective of the method comparison study is to evaluate the clinical utility of the Aptima HIV-1 assay by comparing the results to the FDA-licensed COBAS assay (Roche Molecular Systems, Inc., Branchburg, New Jersey) in plasma samples that have viral loads across the dynamic range of the Aptima HIV-1 assay.

HIV-1 Infection

Gen-Probe, Incorporated468 participantsStarted Jan 2014

Palm Springs, California, United States • San Diego, California, United States • New Haven, Connecticut, United States +6 more locations

COMPLETEDPhase 4299 miles

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

NCT00068809

This study will determine if taking anti-HIV drugs 4 days a week will control HIV-1 viral replication in patients who have already had at least 6 months of documented viral suppression with full-time treatment. If this strategy is shown to be safe in this study, a larger study will be undertaken to determine if the strategy can decrease overall drug exposure and help young people adjust more easily to a chronic medication schedule.

HIV Infections

University of North Carolina, Chapel Hill31 participantsStarted Jul 2003

Los Angeles, California, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +6 more locations

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

HIV/AIDS Trials in Other Cities

A Novel Method to Determine HIV Incidence Among Youth

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

C2P Mobilization Intervention (Pilot)

Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients

Engaging Care for HIV-infected Adolescent Females.

Integrated Treatment of Marijuana Abuse for HIV+ Youth

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

HIV Treatment-Readiness Measure (HTRM) Validation

CDC-ATN Linkage Evaluation

Treatment De-Intensification and Residual HIV-1 in Youth

Factors Affecting PrEP Adherence

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Immunologic Memory (Supp. of ATN 024)

Linkage to Care - Part II

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

PRO 140 for Human Immunodeficiency Virus Infection

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Other Conditions in Phoenix